Raymond James upgraded shares of Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday morning,Zacks.com reports.
Separately, Alliance Global Partners raised shares of Invesco S&P Emerging Markets Low Volatility Index ETF to a “strong-buy” rating in a research report on Thursday, September 26th.
Check Out Our Latest Report on Invesco S&P Emerging Markets Low Volatility Index ETF
Invesco S&P Emerging Markets Low Volatility Index ETF Price Performance
Invesco S&P Emerging Markets Low Volatility Index ETF Company Profile
Elevance Health Inc operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Featured Articles
- Five stocks we like better than Invesco S&P Emerging Markets Low Volatility Index ETF
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Best Stocks Under $5.00
- 3 Buy-and-Hold Stocks for Long-Term Growth
- When to Sell a Stock for Profit or Loss
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Invesco S&P Emerging Markets Low Volatility Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco S&P Emerging Markets Low Volatility Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.
